Year: 2014 | Month: September | Volume 1 | Issue 1

Improvement of Mandibular Bone Mass in Postmenopausal Osteoporotic Patients with the Treatment of Zoledronic Acid

M. I. Majumder M. A. S. I. Harun A. K. Shoma and M. Uddin
DOI:Coming Soon


Aim: The aim of this study was to see the improvement of mandibular bone mass (MABM) in postmenopausal osteoporotic patients treated with bisphosphonate (zoledronic acid). Materials and Methods: A total of 150 postmenopausal osteoporotic patients were divided into two groups under the condition of treated and non-treated. All patients had been evaluated by dual-energy X-ray absorptiometry, radiovesiography. Result: Pixel intensity value of mandibular alveolar bone was significantly different between osteoporosis and treated osteoporosis group (P < 0.05). Conclusion: There are significant improvements of MABM in postmenopausal osteoporotic patient treated with zoledronic acid.

© This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Print This Article Email This Article to Your Friend

International Journal of Dental and Medical Specialty | In Association with SMOD. 35727549 - Visitors since June 1, 2015